Oct 31,2022

JMIR DIABETES | CLINICAL UTILITY OF DIGITAL THERAPEUTIC INTERVENTION WITH TYPE 2 DIABETES

JMIR Publications published "Clinical Utility of a Digital Therapeutic Intervention in Indian Patients With Type 2 Diabetes Mellitus: 12-Week Prospective Single-Arm Intervention Study" in their journal JMIR Diabetes. The aim of this study was to examine the clinical utility of a digital therapeutic intervention (Phable Care) as an add-on therapy to achieve glycemic control in patients with T2DM. A total of 128 participants completed the study period of 12 weeks. At the end of 12 weeks, the mean change in HbA1c, FBG, PPBG, and BMI for the overall study population was –0.84% (P<.001), –8.39 mg/dl (P=.02), –14.97 mg/dl (P<.001), and –0.24 kg/m2 (P=.06), respectively. The digital therapeutic intervention when used alongside standard medications significantly reduces HbA1c, FBG, and PPBG levels in patients with T2DM.

CLINICAL STUDY

#mobile app

#bgm

View Analyst & Ambassador Comments
Go to original news
Jun 14,2023 TOP STORY

Engagement, Retention, and Acceptability in Sidekick Health Program for Atopic Dermatitis: Prospective Interventional Study

Patients with atopic dermatitis can experience chronic eczema with pruritus, skin pain, sleep problems, anxiety, and other problems that reduce their quality of life (QoL). Current treatments aim to improve these symptoms and reduce inflammation, but poor treatment adherence and disease understanding are key concerns in the long-term management of atopic dermatitis. The aim of the study is to test the feasibility of a digital health program tailored for atopic dermatitis through program engagement, retention, and acceptability. A digital health program for patients with atopic dermatitis was developed by Sidekick Health, a digital therapeutics company. The program was delivered through a mobile phone app, designed to engage patients with atopic dermatitis in lifestyle optimization and increase their treatment adherence. A total of 21 patients were recruited (17 female, mean age 31 years), 20 (95%) completed the program. Findings showed high overall engagement and retention in a targeted digital health program among patients with atopic dermatitis, as well as high compliance with missions relating to medication reminders, patient education, and PROs. Symptom number and severity were reduced, and QoL PROs improved over time.

CLINICAL STUDY

#mobile app

View Analyst & Ambassador Comments
Go to original news
Apr 07,2022

A Digital Therapeutic Intervention Is Feasible For Outpatient Care In Coronary Artery Disease

Lifestyle and medication adherence are important factors in secondary coronary artery disease (CAD)-prevention. Furthermore, the mind-heart-body connection is gaining recognition in cardiovascular health management. This study assessed the hypothesis that a CAD-specific digital intervention is feasible for outpatient care in terms of program retention, satisfaction, quality of life, symptom frequency and medication adherence. A four-week CAD-program (SK-121) delivered via a smart phone was designed in collaboration between the National University Hospital of Iceland (NUHI) and Sidekick Health. atient recruitment took place at NUHI, and program participation consisted of daily health promoting missions assigned within the digital intervention such as watching educational videos, mindfulness exercises, medication reminders and logging quality of life scores. In conclusion, a CAD-specific digital intervention is found feasible in terms of engagement, user satisfaction and improved treatment adherence. An RCT study is being planned to further test the program.

CLINICAL STUDY

#mobile app

View Analyst & Ambassador Comments
Go to original news
Apr 07,2022

A Novel Digital Therapeutic Program Is Feasible For Patients With Peripheral Artery Disease

Patients with peripheral artery disease (PAD) are at increased risk for adverse cardiovascular and limb events and impaired quality of life. Lifestyle factors, such as patient physical activity levels and dietary habits, are known risk factors. Limited data is available on the feasibility and efficacy of tailored PAD digital therapeutic programs, focused on improving lifestyle (e.g. physical activity levels, dietary habits, sleep, stress, energy levels) and medication adherence. This study assessed the hypothesis that a digital therapeutic program is feasible among elderly patients with PAD. Patients were recruited from two vascular surgery specialty clinics in Sweden. Fourteen patients signed informed consent forms and started a four-week intervention based on the first weeks of the SK-111 digital program (Sidekick Health). The findings from this feasibility study indicate that a PAD digital therapeutic program is feasible for elderly patients with PAD. A multicenter RCT is currently ongoing, where the clinical effectiveness of the full SK-111 will be further explored in this patient group.

CLINICAL STUDY

#mobile app

View Analyst & Ambassador Comments
Go to original news
Nov 30,2022

Improving outpatient care for heart failure through digital innovation: a feasibility study

 Ideally, HF follow-up and self-care support includes lifestyle-change recommendations and remote monitoring of weight and HF symptoms. Providing these via a digital solution may be ideal for improving HF disease outcomes and reducing the burden on providers and healthcare systems. This study’s main objective was to assess the feasibility of a digital solution including remote monitoring, lifestyle-change, and self-care support for HF outpatients in Iceland. Twenty HF patients (mean age 57.5 years, 80% males) participated in an 8-week study. They were provided with a digital solution (Sidekick health), including lifestyle-change and disease self-care support, a remote symptom monitoring system, and a secure messaging platform between healthcare providers and patients. This feasibility study aimed to assess patient acceptability of this new intervention, retention rate, and to evaluate trends in clinical outcomes. The digital solution, SK-141, was very acceptable to patients and also showed promising clinical results in this small feasibility study.

CLINICAL STUDY

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jul 17,2020

A Digital Lifestyle Program in Outpatient Treatment of Type 2 Diabetes: A Randomized Controlled Study

Lifestyle is important in type 2 diabetes mellitus (T2DM). This study’s aim was to investigate whether a healthy-lifestyle-supporting smartphone application could affect treatment outcomes at an endocrinology outpatient clinic.  In addition to standard care, intervention group participants used a smartphone application to access a lifestyle program (SidekickHealth) through which they received personalized recommendations and education about healthy lifestyles. Results indicate that the SidekickHealth digital lifestyle program could potentially enhance outpatient treatment in T2DM, in terms of both glycemic control and psychological well-being but larger confirmative studies are needed.

CLINICAL STUDY

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jul 17,2020

A Digital Lifestyle Program in Outpatient Treatment of Type 2 Diabetes: A Randomized Controlled Study

Lifestyle is important in type 2 diabetes mellitus (T2DM). This study’s aim was to investigate whether a healthy-lifestyle-supporting smartphone application could affect treatment outcomes at an endocrinology outpatient clinic. In addition to standard care, intervention group participants used a smartphone application to access a lifestyle program (SidekickHealth) through which they received personalized recommendations and education about healthy lifestyles. Results indicate that the SidekickHealth digital lifestyle program could potentially enhance outpatient treatment in T2DM, in terms of both glycemic control and psychological well-being but larger confirmative studies are needed.

CLINICAL STUDY

#mobile app

View Analyst & Ambassador Comments
Go to original news
May 04,2022

Sidekick’s Feasibility Study Shows Encouraging Results for Breast Cancer Patients

Digital interventions can effectively improve pain, fatigue, stress and overall health-related quality of life. The study was a four-week, single-arm feasibility trial. Eighteen female participants with breast cancer were recruited from The Light (Ljósið), a cancer rehabilitation clinic in Iceland. Participants had a mean age of 50 years and were overweight or obese with a mean BMI of 30, and all had ongoing cancer treatment involving either radiotherapy, chemotherapy, or both. Participants were asked to register in the app, and had a number of interventional tools available to use including: Food logging, Activity tracking and step count, Surveys, Receiving educational content on mindfulness, sleep, stress management, and nutrition. Overall, all but one participant was engaged in the app every week, with 67% of the participants being ‘highly’ engaged which means that they interacted with the app at least five days a week. The largest improvement in symptoms was observed in pain scores, which decreased for over 50% of participants (non-significant). 

CLINICAL STUDY

#mobile app

View Analyst & Ambassador Comments
Go to original news
May 04,2022

Sidekick’s Feasibility Study Shows Encouraging Results for Breast Cancer Patients

Digital interventions can effectively improve pain, fatigue, stress and overall health-related quality of life. The study was a four-week, single-arm feasibility trial. Eighteen female participants with breast cancer were recruited from The Light (Ljósið), a cancer rehabilitation clinic in Iceland. Participants had a mean age of 50 years and were overweight or obese with a mean BMI of 30, and all had ongoing cancer treatment involving either radiotherapy, chemotherapy, or both. Participants were asked to register in the app, and had a number of interventional tools available to use including: Food logging, Activity tracking and step count, Surveys, Receiving educational content on mindfulness, sleep, stress management, and nutrition. Overall, all but one participant was engaged in the app every week, with 67% of the participants being ‘highly’ engaged which means that they interacted with the app at least five days a week. The largest improvement in symptoms was observed in pain scores, which decreased for over 50% of participants (non-significant). 

CLINICAL STUDY

#dtx

#mobile app

View Analyst & Ambassador Comments
Go to original news
Oct 13,2022

Evaluating the Feasibility of a Digital Therapeutic Program for Patients With Cancer During Active Treatment: Pre-Post Interventional Study

Increasing evidence shows that lifestyle interventions can improve the symptoms, quality of life (QoL), and even overall survival of patients with cancer. Digital therapeutics (DTx) can help implement behavioral modifications and empower patients through education, lifestyle support, and remote symptom monitoring. The study aimed to test the feasibility of a DTx program from Sidekick Health for patients with cancer, as measured by engagement, retention, and acceptability, in a 4-week single-arm trial in Iceland, where DTx was delivered through a smartphone app. The high retention, engagement, and acceptability found in this study demonstrate that multidisciplinary DTx is feasible for patients with cancer. A longer, full-scale randomized controlled trial is currently being planned to evaluate the efficacy of the intervention.

CLINICAL STUDY

#mobile app

#coaching

View Analyst & Ambassador Comments
Go to original news
Subscribe to CLINICAL STUDY